Outcome Measures: |
Primary: To assess the efficacy of L-Carnitine containing PD solution on insulin sensitivity evaluated by euglycemic hyperinsulinemic clamp, time 0, 4 months | Secondary: To assess the efficacy of L-Carnitine containing PD solution on plasma lipids and lipoprotein profile, -2 weeks, time 0, 1 month, 2 months, 3 months, 4 months|To assess the efficacy of L-Carnitine containing PD solution on hematological parameters (hemoglobin and EPO requirements), -2 weeks, time 0, 2 months, 4 months
|
Locations: |
Renal and Dialysis, Bari Policlinic Hospital, Bari, 70124, Italy|Renal, Dialysis and Transplant Unit, University of Bari, Bari, 70124, Italy|Division of Nephrology, University of "G. d'Annunzio", Chieti, 66100, Italy|Nephrologyand Dialysis Unit, Desio Hospital, Desio, 20100, Italy|Nephrology and Dialysis Unit, "Maria SS dello Splendore" Hospital, Giulianova, 64021, Italy|Nephrology and Dialysis Unit, "Renzetti" Hospital, Lanciano, 66034, Italy|Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore, Milano, 20121, Italy|Nephrology and Dialysis Unit, "G. Bernabeo" Hospital, Ortona, 66026, Italy|Renal Unit, Policlinico MultiMedica, Sesto San Giovanni, 20099, Italy|Nephrology and Dialysis Unit, "SS Annunziata" Hospital, Sulmona, 67039, Italy|Division of Nephrology and Dialysis, "Mazzini" Hospital, Teramo, 64100, Italy|Nephrology and Dialysis Unit, "San Pio da Pietrelcina" Hospital, Vasto, 66054, Italy
|